Publicaciones en colaboración con investigadores/as de Instituto Universitario de Oncologia del Principado de Asturias (78)

2024

  1. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma

    eBioMedicine, Vol. 102

2023

  1. Analysis of ATG4C function in vivo

    Autophagy, Vol. 19, Núm. 11, pp. 2912-2933

  2. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors

    Cancer research, Vol. 83, Núm. 2, pp. 239-250

2022

  1. Classification of follicular-patterned thyroid lesions using a minimal set of epigenetic biomarkers

    European journal of endocrinology, Vol. 187, Núm. 3, pp. 335-347

  2. Differential HIF2α Protein Expression in Human Carotid Body and Adrenal Medulla under Physiologic and Tumorigenic Conditions

    Cancers, Vol. 14, Núm. 12

  3. Mechanical ventilation promotes lung tumour spread by modulation of cholesterol cell content

    The European respiratory journal, Vol. 60, Núm. 1

  4. Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. Epigenetic Deregulation of the Histone Methyltransferase KMT5B Contributes to Malignant Transformation in Glioblastoma

    Frontiers in Cell and Developmental Biology, Vol. 9

  2. Immune cell infiltrates and neutrophil-to-lymphocyte ratio in relation to response to chemotherapy and prognosis in laryngeal and hypopharyngeal squamous cell carcinomas

    Cancers, Vol. 13, Núm. 9

2020

  1. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis

    International Journal of Cancer, Vol. 146, Núm. 2, pp. 373-387

  2. Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma

    Oral Oncology, Vol. 110

2019

  1. New chondrosarcoma cell lines with preserved stem cell properties to study the genomic drift during in vitro/in vivo growth

    Journal of Clinical Medicine, Vol. 8, Núm. 4

  2. The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas

    International Journal of Cancer, Vol. 145, Núm. 1, pp. 254-266

2018

  1. Epigenetic dysregulation of TET2 in human glioblastoma

    Oncotarget, Vol. 9, Núm. 40, pp. 25922-25934

  2. FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway

    Neoplasia (United States), Vol. 20, Núm. 1, pp. 44-56

  3. Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma

    Human Molecular Genetics, Vol. 27, Núm. 17, pp. 3046-3059

  4. Loss of the deubiquitinase usp36 destabilizes the rna helicase dhx33 and causes preimplantation lethality in mice

    Journal of Biological Chemistry, Vol. 293, Núm. 6, pp. 2183-2194

  5. Preventing loss of mechanosensation by the nuclear membranes of alveolar cells reduces lung injury in mice during mechanical ventilation

    Science Translational Medicine, Vol. 10, Núm. 456

  6. TP53 p.R72P genotype is a marker of poor prognosis in lung cancer

    Cancer Biomarkers, Vol. 21, Núm. 4, pp. 747-754

2017

  1. A Novel Role for Nanog As An Early Cancer Risk Marker in Patients with Laryngeal Precancerous Lesions

    Scientific Reports, Vol. 7, Núm. 1